Rivernorth Capital Management LLC Has $28.41 Million Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Rivernorth Capital Management LLC decreased its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 9.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,793,725 shares of the company’s stock after selling 182,682 shares during the quarter. BlackRock Health Sciences Term Trust accounts for approximately 1.4% of Rivernorth Capital Management LLC’s holdings, making the stock its 21st biggest holding. Rivernorth Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $28,413,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Dakota Wealth Management grew its position in BlackRock Health Sciences Term Trust by 5.3% in the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after acquiring an additional 915 shares during the period. Oppenheimer & Co. Inc. boosted its stake in shares of BlackRock Health Sciences Term Trust by 0.6% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after purchasing an additional 1,153 shares in the last quarter. Brown Brothers Harriman & Co. bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth about $32,000. Brown Lisle Cummings Inc. increased its position in shares of BlackRock Health Sciences Term Trust by 6.2% during the 3rd quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after purchasing an additional 2,128 shares in the last quarter. Finally, Comerica Bank lifted its holdings in BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after purchasing an additional 3,671 shares during the last quarter.

Insider Activity at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. purchased 15,455 shares of the firm’s stock in a transaction dated Thursday, September 19th. The shares were acquired at an average cost of 16.14 per share, with a total value of 249,443.70. Following the completion of the purchase, the insider now directly owns 20,601,568 shares of the company’s stock, valued at 332,509,307.52. This trade represents a 0.08 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 99,630 shares of company stock valued at $1,585,113 in the last three months.

BlackRock Health Sciences Term Trust Stock Performance

NYSE:BMEZ opened at 15.50 on Friday. BlackRock Health Sciences Term Trust has a 12 month low of 14.27 and a 12 month high of 16.59. The company’s 50-day moving average price is 15.62 and its two-hundred day moving average price is 15.62.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 16th will be given a dividend of $0.1781 per share. The ex-dividend date is Monday, December 16th. This represents a $2.14 dividend on an annualized basis and a yield of 13.79%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.